Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner

Tenofovir (TFV) is used in combination with other antiretroviral drugs for human immunodeficiency virus (HIV) treatment and prevention. TFV requires two phosphorylation steps to become pharmacologically active; however, the kinases that activate TFV in cells and tissues susceptible to HIV infection...

Full description

Bibliographic Details
Main Authors: Lade, Julie M., To, Elaine E., Hendrix, Craig W., Bumpus, Namandjé N.
Format: Online
Language:English
Published: Elsevier 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588390/